FSSAI Takes Legal Action Against Nestlé India Over Baby Food
- 1FSSAI initiated legal action against Nestlé India on Friday, 18 September 2026, for alleged violations in three infant nutrition products, though the company maintains full compliance.
- 2The regulator has banned sales of Cerelac Wheat with Milk (Stage-1) and two NAN PRO infant formula variants, citing violations of the Infant Milk Substitutes Act and Food Safety Standards regulations.
- 3Nestlé India denies wrongdoing, asserting all products meet regulatory requirements and have necessary approvals.
- 4The legal proceedings will unfold in local courts with potential implications for product availability and brand reputation in India's infant nutrition category.
- 5This marks a critical regulatory challenge for one of India's largest FMCG players in a category under intense public health scrutiny.
Regulatory scrutiny intensifies as food authority challenges compliance claims on infant nutrition products.
The Food Safety and Standards Authority of India (FSSAI) has launched legal proceedings against Nestlé India over alleged regulatory violations in three infant nutrition products, marking a significant escalation in the oversight of India's baby food market. On Friday, 18 September 2026, the regulator announced it had initiated legal action while simultaneously banning the sale of the implicated products—Cerelac Wheat with Milk (Stage-1) and two variants of NAN PRO infant formula. The move represents one of the most high-profile regulatory challenges faced by the Swiss FMCG giant's Indian operations in recent years, raising critical questions about compliance frameworks and brand vulnerability in highly regulated categories.
The Regulatory Challenge
FSSAI's action centres on alleged violations of the Infant Milk Substitutes, Feeding Bottles and Infant Foods (IMS) Act and the Food Safety and Standards (Health Supplements, Nutraceuticals, Foods for Special Dietary Use, Foods for Special Medical Purpose, Functional Foods and Novel Food) Regulations, 2016. The regulator has specifically targeted Cerelac Wheat with Milk (Stage-1), NAN PRO 1 (0-6 months), and NAN PRO 2 (6-12 months), ordering an immediate sales ban. For brand managers in the infant nutrition space, this enforcement action signals heightened regulatory vigilance in a category that intersects public health policy, consumer protection, and commercial interests. The legal proceedings will unfold in local courts, creating uncertainty around product availability and market positioning during the critical September-December quarter when infant product sales typically peak.
Nestlé's Counter-Position
Nestlé India has firmly rejected the allegations, issuing a statement asserting "full compliance" with all applicable regulations. The company maintains that its products have received necessary approvals from FSSAI and meet prescribed standards. This divergence between regulatory assessment and corporate position creates a complex narrative challenge for the brand. For marketing and communications teams managing FMCG portfolios, the Nestlé response offers a case study in crisis positioning—balancing regulatory respect with brand defence. The company's public assertion of compliance, while legal action proceeds, reflects the tightrope walk between protecting brand equity and acknowledging regulatory authority. Senior marketers will recognise this as a high-stakes reputation management scenario where every communication carries legal, commercial, and stakeholder implications.
Category and Market Implications
The infant nutrition category in India operates under uniquely stringent oversight due to public health considerations and the vulnerability of the target consumer group. With growing middle-class awareness of infant nutrition and increasing scrutiny of multinational food companies, regulatory actions carry amplified reputational risk. The timing of this enforcement—in September 2026—coincides with broader global conversations about infant food standards and corporate responsibility. For competing brands in the category, this presents both opportunity and caution: opportunity to capture market share, but caution about their own compliance frameworks coming under similar scrutiny. Category managers across FMCG portfolios should note that regulatory enforcement in one brand often triggers broader sectoral audits, making this a potentially industry-wide issue rather than an isolated corporate challenge.
This legal action against Nestlé India represents a watershed moment in the evolution of regulatory-brand relationships in India's FMCG sector. The confidence with which FSSAI has moved to ban products and initiate legal proceedings suggests a regulatory body increasingly willing to challenge even the most established multinational corporations. For brand strategists, this signals a fundamental shift in the risk profile of operating in highly regulated categories in India. The days when corporate reputation and market leadership provided implicit protection against aggressive enforcement appear to be ending. Marketing leaders must now factor in regulatory risk as a primary consideration in portfolio strategy, product innovation, and market communication—not merely as a compliance afterthought.
The divergence between Nestlé's compliance claims and FSSAI's enforcement action also reveals the complexity of India's regulatory landscape. Different interpretations of the same regulatory framework can create significant business disruption. This ambiguity demands that marketing and legal teams work in closer integration, ensuring that product positioning, claims, and go-to-market strategies are not just creatively compelling but defensibly compliant. The reputational stakes in the infant nutrition category are particularly acute because they involve child health and parental trust—two factors that can irreversibly damage brand equity if mishandled. How Nestlé navigates the next phase of this legal challenge will offer crucial lessons in crisis management, stakeholder communication, and regulatory diplomacy for India's marketing community.
Regulatory compliance in India has evolved from a back-office function to a frontline brand risk that demands C-suite attention. For marketers managing portfolios in health, nutrition, and child-focused categories, this Nestlé-FSSAI confrontation underscores the need for robust compliance frameworks, transparent stakeholder communication, and rapid response capabilities. The ability to navigate regulatory challenges while protecting brand equity will increasingly distinguish market leaders from market laggards in India's maturing consumer economy. Senior marketers must ensure their organisations are prepared not just to comply with regulations, but to proactively engage with regulators and communicate with clarity when challenges arise.
This article is an editorial rewrite based on reporting originally published by Outlook Business. The original article has been rewritten and contextualised for India's marketing community by The Wise Marketing Desk using AI-assisted editorial tools.
Read original article at Outlook BusinessFound this useful? Share it with your network.
Get India's best marketing news, daily.
Join 5,000+ marketing professionals reading The Wise Marketing.